We found that the levels of c-myc were significantly decreased in irradiated shRNAper1-transfected glioma cells and that c-myc overexpression induced genomic DNA damage and compromised p53 function, presumably via a reactive oxygen species-mediated mechanism. This evidence concerns the gene TP53 and central nervous system cancer.